Evidence map›Paper›PMID 42606136›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

F7 Drives Gastric Cancer Metastasis Through Anoikis Resistance and Tumor Microenvironment Remodeling.

Lei Gao, Qinying Han, Yunpeng Wang, Xuemei Li, Bofang Wang, Baohong Gu, Weidong Li, Lin Xiang, Ying Zhang, Hao Chen

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lei GaoThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.ORCID https://orcid.org/0000-0001-8810-3095
Qinying HanThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
Yunpeng WangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
Xuemei LiThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
Bofang WangCancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Baohong GuCancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Weidong LiThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
Lin XiangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.
Ying ZhangDepartment of Laboratory Medicine, the First Medical Centre, Chinese PLA General Hospital, Beijing, People's Republic of China.
Hao ChenThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People's Republic of China.ORCID https://orcid.org/0000-0003-0018-480X

Funding

Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital CY2023-QN-A01Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital CY2023-ZD-01Gansu Province Postgraduate, Innovation Star Program 2025CXZX-115Gansu Province Science and Technology Plan Project 24JRRA373General Project of Gansu Province Joint Research Fund 24JRRA929Key Project of Science and Technology in Gansu province 22ZD6FA054Key Talents Project of Gansu Province 2019RCXM020Major scientific research project for scientific and technological innovation in the health industry of Gansu Province GSWSZD-2024-17National Natural Science Foundation of China 82160129National Natural Science Foundation of China 82473266National Natural Science Foundation of China 82560488
6 · The paper itself

Abstract

Coagulation factor VII (F7) has been implicated in tumor progression; however, its role in gastric cancer metastasis and immune evasion remains incompletely understood. In this study, we identified F7 as a clinically relevant driver of gastric cancer. F7 was highly expressed in tumor tissues and closely associated with lymph node metastasis, poor prognosis, and reduced CD8

Indexed as

extracellular matrixgastric cancerimmune checkpoint inhibitorimmunosuppressiontumor microenvironment (TME)

Identifiers

PMID42606136
PMCPMC13479850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.